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
Environmental substances like polychlorinated biphenyls and dietary fatty acids have 
been suspected to influence cognitive functions in humans, although much of their 
specific effects on synaptic functions are still unclear. There are many contradicting 
studies of the cognitive benefits of polyunsaturated fatty acids. In some studies it is 
emphasized that children with cognitive impairments such as ADHD, may have 
impaired fatty acid metabolism, implicating that the genetic status may be of 
importance. Ingestion of polychlorinated biphenyls have been associated with 
negative effects on cognitive processes, although the effects seems to be highly 
dependent on their molecular structure exposure time, duration, doses. In this thesis, 
the effect of dietary fat content and polychlorinated biphenyl 153 was investigated in 
neostriatal dopaminergic synapses and included measurements of related 
neurotransmitters like e.g glutamate and serotonin.  
We included both male and female rats of two different genotypes namely the Wistar 
Kyoto rats and the spontaneously hypertensive rats as an animal model of ADHD, to 
investigate if genetic and hormonal status may influence the effect of these 
compounds. Initially the dietary study involved two distinct diets, one with a low level 
of dietary fatty acids (5%, w/w) with the other one supplemented with omega-3 
polyunsaturated fatty acids (equal amounts of EPA and DHA) containing a high level 
of fatty acids (21%, w/w). The omega-3 supplementation led to gender dependent 
improvement in behaviour in the male SHRs, and included reduced levels of 
reinforcer-controlled activity, impulsiveness and inattention, with no or opposite 
effects in the female SHRs. Further biochemical studies on the neostriatal 
dopaminergic system, involved in reinforcement of behaviour, confirmed that the 
male SHRs had a reduction of the dopamine content in concert with enhanced 
homovanillic acid and calculated turnover ratio of dopamine, all of which were absent 
in the female SHRs. To further investigate if the effects achieved by omega-3 
supplementation (this time with 80% DHA and 20% EPA), could be specific for 
omega-3 fat, we included an extra diet composed of high levels of fatty acids (21%, 
w/w) containing mainly lard which is rich in both saturated (40%) and polyunsaturated 
fats (60%) but with low levels of omega-3. In this second round  we discovered that in 
the male WKY rats, both the lard and omega-3 enriched diets gave reduced levels of 
dopamine, tyrosine hydroxylase and vesicular monoamine transporter-2, without 
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changing the extracellular dopamine metabolite homovanillic acid in neostriatum. In 
contrast to the lard enriched diet, omega-3 enrichment induced an additional 2-fold 
increase in dopamine turnover ratio in the male WKYs, as well as a significant 
decrease in the levels of the dopamine transporter. Another finding was that the 
young male SHRs at p30 were hypodopaminergic compared to age and gender 
matched WKYs. In these male SHRs, the 40% lower dopamine turnover ratio was 
reversed 2-fold, to a similar extent by both lard and omega-3 enriched diets, without 
any significant effects on the protein levels.  
These findings show that dietary fatty acid composition may strongly influence the 
neostriatal dopaminergic system in a gender and genotype dependent way, with both 
type of fatty acids as well as the amounts influencing the synaptic responses. 
Polychlorinated biphenyls (PCBs) can be separated into ortho- and non ortho-
substituted PCBs, where most of the ortho-substituted being neurotoxic and possibly 
interrupt cognitive functions. In this thesis we employed the ortho-substituted PCB 
153, which is one of the most abundant PCB found in mammalian milk. 
Biochemical studies were performed on dopamine and serotonin neurotransmitters 
as well as amino acids in the neostriatum of both genders from the Wistar Kyoto 
(WKY) and the spontaneously hypertensive rat (SHR) genotypes. Exposure to PCB 
153 led to increases in homovanillic acid and 5-hydroxyindoleacetic acid in all groups 
except the female SHRs, whereas levels of dopamine and serotonin 
neurotransmitters as well as amino acids were unchanged in all genotypes and 
genders. PCB-153 also induced a decrease in the neostriatal D5 receptor in both 
genders and genotypes, without changing the D1 receptor. In contrast, levels of the 
dopamine transporter were reduced in the male WKYs, together with an insignificant 
reduction of the mean in the male SHRs. In addition, a gender-specific decrease of 
the PSD-95 protein occurred in the PCB-exposed male rats. Levels of tyrosine 
hydroxylase and vesicular monoamine transporter-2 were unchanged in all animals 
examined. Therefore, postnatal PCB exposure had major effects on both dopamine 
and serotonin turnover as well as specific PCB-sensitive synaptic proteins. 
Differences occurred between the effects obtained in both genotypes, as well as 
between genders. Altogether, this set of studies shows that both PCB 153 and 
dietary fatty acids, environmental compounds suspected to influence cognitive 
functions, may modulate neostriatal dopaminergic synapses in distinct gender and 
genotype dependent ways. 
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5-HIAA   5-Hydroxyindole acetic acid
ADHD    Attention deficit hyperactivity disorder    
cAMP    Cyclic adenosine monophosphate         
COMT   Catechol-o-methyl transferase                   
DAT    Dopamine transporter  
DHBA    3, 4-hydroxybenzylamine 
DHA    Docohexaenoic acid 
D1/5R    Dopamine receptor D1/D5 
EPA    Eicopentaenoic acid 
GABA    Ȗ-amino butyric acid 
HPLC    High performance liquid chromatography 
HVA    Homovanillic acid 
LFA    Low fatty acid 
LTD    Long term depression 
LTP    Long term potentiation 
MOA    Monoamine oxidase 
n-3    Omega-3 
P    Postnatal day 
PCB     Polychlorinated biphenyl 
PUFA    Polyunsaturated fatty acids 
SHR    Spontaneously hypertensive rats 
SFA    Saturated fatty acids 
TH     Tyrosine hydroxylase 
VMAT-2    Vesicular monoamine transporter-2 
WKY    Wistar Kyoto rats 
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ͳǤ
ͳǤͳ
Neuronal circuits communicate through the use of neurotransmitters and receptors. The 
functional dynamics of neurons are changing trough out the life cycle in response epigenetics 
and frequency of stimulations, stress, nutrition or other environmental factors like neuro-
active toxins or pharmaceuticals (Bowers et al., 2010;Johannessen, 1991;Zainuddin & Thuret, 
2012;Timmermans et al., 2013;Bliss & Cooke, 2011;Takesian & Hensch, 2013). Disturbances 
to functional neuronal processes could lead to more or less maladaptive strategies of living 
and to psychological disorders. Among several neurotransmitters, glutamate, dopamine are 
believed to be important in cognitional processes. For glutamate, changes in plasticity like 
long-term potentiation (LTP) or long-term depression (LTD) which is dependent upon 
glutamatergic signalling, has been associated with memory and learning (Bliss & 
Collingridge, 1993). Studies have implicated that dopaminergic neurons might be important 
mediators of reward and involved in regulating aspects of cognitive functions (Schultz, 
2007;Nieoullon, 2002). Changes in glutamatergic and dopaminergic  neurotransmission have 
also been suggested to be involved in one of the most common cognitive childhood disorder 
named,  attention deficit hyperactivity disorder (ADHD). The symptoms of this disorder 
involve severe attention deficit, but also impulsivity and hyperactivity. The world-wide 
prevalence of ADHD is ~5 % and although it is mainly genetic, twin-studies show only ~76 
% heredity, leading to proposals of environmental impact. Environmental factors which have 
been suggested include maternal smoking, alcohol, poor diet as well as organic environmental 
toxins, although, no clear effect or single explanation has been found in epidemiological 
studies (Banerjee et al., 2007). In this thesis I am going to focus on two carefully selected 
environmental factors that have been proposed to influence synaptic cognitional processes by 
modulating synaptic functions; 1) Dietary lipids and 2) Polychlorinated biphenyls (PCBs). 
Since earlier studies have implicated that both lipids and PCBs might influence cognitive 
functions (Winneke, 2011), we chose to focus on the dopaminergic dynamics of striatum 
(involved in reward and reinforcing mechanisms), and the glutamatergic dynamics in 
hippocampus (involved in memory formation). We also wanted to explore if a rodent model 
with ADHD-linked gene pool (SHR) inhabit the same sensitivity for environmental factors as 
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its control (WKY), and also if there is gender-related responses. In this thesis we therefore 
studied neurologic effects of dietary lipids and PCB on the rat model (SHR) of cognitive 
deficits (ADHD) and its control (WKY).  
ͳǤʹ
ADHD is highly common and normally diagnosed during childhood, although 
diagnosis in adults have become more common the last decades (Polanczyk et al., 
2007). According to World health organization and American Psychiatric Association, 
ADHD are defined by 18 different symptoms of inattention, hyperactivity and 
impulsivity. The symptoms must been present for at least six months and represent a 
level that is maladaptive in relation to the age, as well as onset of symptoms before the 
age of seven years. The common symptoms of ADHD can be followed by severe 
comorbidities that might lead to reduction of life quality (learning problems, conduct 
disorder, anxiety,  speech problems, increased chance of drug addiction and increased 
risk taking) (Larson et al., 2011;Reinhardt & Reinhardt, 2013). ADHD is a male-
dominated disorder, with three times more boys being diagnosed than girls. Further, 
symptoms differ between the genders with males usually express more severe 
hyperactivity and females often are more likely to be mainly inattentive (Weiss et al.,
2003). Because of different combinations of symptoms expressed among the patients, 
ADHD diagnosis consists of three sub-diagnoses. Primarily we have the typical 
ADHD combined (ADHD-C) subtype with all the main symptoms including attention 
deficit, hyperactivity and impulsivity, affecting boys three times more than girls. 
Secondly we have the primarily inattentive (ADHD-PI) subtype, characterized by 
inattention and a lack of focus leading to increased daydreaming, mind wandering and 
forgetfulness. The ADHD-PI subtype diagnosis is more frequent among girls than 
ADHD-C, since girls often show less external hyperactivity and impulsiveness. The 
last subtype is the hyperactive and impulsive subtype (ADHD-H), where the 
individuals express mainly these symptoms without being inattentive (Weiss et al.,
2003). Twin-studies have given evidence that this is a multifactorial and primarily 
inheritable disorder due to several polymorphisms; while a small part are thought to be 
environmental (Faraone et al., 2005). Although increased amounts of polymorphisms 
have been found in ADHD patients, the variability was so large that  no single genetic 
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marker has been identified. Therefore it has been suggested that the polymorphisms 
associated with ADHD might hold increased sensitivity for epigenetic and 
environmental factors (Thapar et al., 2013). First choice medications 
(psychostimulants) are ineffective in 20% of all cases, and some patients may require 
special combinations of medication (Wigal, 2009). This shows that the underlying 
mechanisms are complex and incompletely understood. It is important to gain more 
understanding about the underlying neurobiology of ADHD. In this thesis I will 
concentrate my work around neurochemical parameters believed to be important in 
ADHD, both in normal rats (WKY)  and the rat animal model of ADHD-C (SHR), as 
well as exploring gender-dependent responses to our interventions. 

In mammalian brain, neurotransmitters can be divided into amino acid transmitters 
(like glutamate and GABA), catecholamine's (dopamine and noradrenaline), 
indoloamines (serotonin), acetylcholine or neuropeptides. The catecholamine's like 
dopamine and noradrenaline are derived from the amino acid tyrosine while the 
monoamine serotonin is derived from the amino acid tryptophan. With regard to 
ADHD especially neurons involving dopamine, noradrenaline, serotonin, glutamate 
and GABA is of interest, since abnormalities have been associated with these 
neurotransmitter systems (Bralten et al., 2013;Yang et al., 2013;Edden et al.,
2012;Gold et al., 2014;Sagvolden et al., 2005a). Although all these neurotransmitter 
systems are tightly connected and might influence each other, I have chosen to focus 
this thesis mainly on the dopaminergic neurotransmitter system, while including some 
serotonergic and amino acidergic analyses. 

ͳǤ͵
The dopamine producing neurons are mainly present in the substantia nigra, the 
ventral tegmental area and hypothalamus. These neurons have widely projecting axons 
and are forming four important signalling pathways namely the nigrostriatal-, 
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mesocolimbic-, mesocortical- and tuberoinfundibular pathway (Dahlstrom & FUXE, 
1964;Anden et al., 1964). Dopamine has an important modulatory role in the brain 
where it influences motor function and reward processes leading to motivation and 
different forms of learning (Nieoullon, 2002). The respective dopaminergic pathways 
innervate a variety of brain tissues. Here they modulate different functional aspects, 
such as motoric control (nigrostriatal system), feelings of reward and desire 
(mesolimbic), motivation, emotional and cognitive control (mesocortical) as well as 
hormonal release (tuberoinfundibular). Diseases and conditions which  involves the 
these systems, includes Parkinson disease, schizophrenia, restless leg syndrome and 
ADHD (Morales & Root, 2014). Drugs targeting the dopaminergic neurons might 
therefore modulate a diverse set of systems that might influence several brain 
functions. 

Dopamine is mainly synthetized from L-tyrosine by the stereospecific enzyme, 
tyrosine hydroxylase (TH). TH is exclusively present in catecholaminergic neurons 
and represents the rate-limiting step in the biosynthesis of dopamine (Bademci et al.,
2012). After production, dopamine is concentrated into synaptic vesicles by the proton 
gradient- and ATP-dependent vesicular monoamine transporter-2 (VMAT-2), for 
storage and release (Varoqui & Erickson, 1998). The VMAT family in mammals 
include two isoform of the vesicular monoamine transporter; VMAT-1 and VMAT-2, 
where VMAT-2 is the only isoform expressed in the brain (Sudhof, 2004;Weihe et al.,
1994). 
After an excitatory stimulus, exocytosis of vesicles releases dopamine into the synaptic 
gap where it diffuses and may stimulate five types of G-protein coupled receptors (D1-
D5) (Missale et al., 1998). The dopamine receptors are divided in two main groups 
called D1-class and D2-class receptors, based on their ability to activate adenylyl 
cyclase. Activation of adenylyl cyclase induces formation of cyclic adenosine 3`,5`-
monophosphate (cAMP) and may lead to phosphorylation of phosphoprotein-32 and 
inhibition of dephosphoryllation (Greengard 2001). The D1-class receptor group 
includes the D1- and D5-receptor and are bound to G-proteins called Golf or Gs that are 
12
cAMP inducing. The D2-class receptors, including D2-, D3- and D4-receptor, are 
coupled to Gi where stimulation inhibits cAMP formation (Missale et al., 1998). The 
distribution and combination of dopamine receptor subtypes in different brain parts are 
also characteristic. This demonstrates that the different brain parts and functions are 
most likely dependent on diverse dopamine receptor subtypes and their unique 
properties (Beaulieu & Gainetdinov, 2011). 
Action of extracellular DA is terminated by presynaptic reuptake by the dopamine 
transporter (DAT), which is a sodium coupled symporter (Sudhof, 2004). Free 
dopamine not capsuled by vesicles may be candidates for degradation by monoamine 
oxidase (MAO) and Catechol-O-methyltransferase (COMT) to homovanillic acid 
(HVA). The balance between TH-activity, DAT, VMAT-2 and the receptors, are 
therefore important factors controlling dopamine signalling. 
Ǧ
The subgroups of dopamine receptors can be distinguished by ability to induce cAMP 
formation and their ways of dealing with guanosine triphosphate. In addition they have 
characteristic agonists and antagonists as well as individual affinity for dopamine. The 
D1- and D5-receptor have SKF-38393 and SCH-23390 as a characteristic agonist and 
antagonist respectively, and their affinity for dopamine is micromolar and 
submicromolar respectively. In addition the D5-receptor is the only subtype that does 
not regulate guanosine triphosphate. The characteristic agonists for D2-, D3- and D4-
receptor are bromocriptine, 7-OH-DPAT and CP-226269 PD respectively, whereas 
their affinity for dopamine is micromolar, nanomolar and submicromolar respectively. 
Ligands for these receptors are mainly used as research tools for investigation of 
dopaminergic function, although some of them potentially can be used as therapeutics 
(Mailman et al., 2001). 

Many drugs like psychostimulants, antidepressants as well as recreational drugs like 
cocaine, are targeted for DAT (Wang et al., 2013). Ligands of DAT might be divided 
in two groups, inhibitors and substrates where the inhibitors will block monoamine 
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uptake without being translocated, whereas substrates are actively translocated and 
triggers DAT-mediated release of dopamine by a reverse translocation cycle (Schmitt 
et al., 2013). Both groups of DAT ligands are contributing to increase in extracellular 
dopamine and might lead to addiction. 

Dopamine is the precursor of noradrenaline, dysregulation of dopamine- and 
noradrenaline seems to be highly associated with ADHD. Methylphenidate and d-
amphetamine are first choice pharmaceuticals for treating ADHD, and works by 
modulating the monoaminergic system as well as inhibiting DAT (Dopheide & 
Pliszka, 2009). Methylphenidate might also be an cognitive enhancer in healthy 
individuals (Linssen et al., 2014). Based on the dynamic development theory it is 
hypothesized that altered dopmainergic function plays a central role by failing to 
modulate non-dopaminergic targets primarily including glutamatergic and GABAergic 
neurons (Sagvolden et al., 2005a). According to this theory three of the main 
dopaminergic pathways can potentially be dysfunctional, giving rise to the three main 
symptoms respectively. The involved dopaminergic signalling pathways are; 1) the 
mesolimbic, where impairment results in altered reinforcement of behaviour and 
deficient extinction mechanisms, 2) the mesocortical pathway where impaired 
signalling results in attention deficiencies and poorer behavioural planning and 3) the 
nigrostriatal dopaminergic pathway where impairment will cause altered motor 
function (hyperactivity/hypoactivity) and nondeclarative habit learning and memory 
(Sagvolden et al., 2005a). 
ͳǤͶ
Glutamate is the most abundant excitatory neurotransmitter in the central nervous 
system (Zhou & Danbolt, 2014). It is thought to contribute in memory formation 
associated processes and are important  for neuronal communication, conversely, 
glutamatergic overstimulation can lead to neuronal damage (Zhou & Danbolt, 
2014;Rothman & Olney, 1995;Bliss & Collingridge, 1993). It is therefore important to 
keep the activity levels in a controlled normalized range. To keep the excitatory 
glutamate stimuli under control it is important that these neurons are tightly connected 
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to well-functioning GABAergic neurons, as GABA is the main transmitter for 
damping excitatory stimulation. Glutamate is also the main neurotransmitter of the 
hippocampus and are involved in memory formation processes and developmental 
plasticity. Memory formation has been suggested to involve processes like long-term 
potentiation (LTP) or long-term depression (LTD) (Bliss & Collingridge, 1993). LTP 
is the measure of long-term-changes in synaptic plasticity and is mostly studied in the 
CA1 area at the Schaffer collaterals or in the structural hippocampal layers; stratum 
oriens and radiatum (Niemi et al., 1998;Herwerth et al., 2012). Although, it is also 
present in limbic forebrain and the entorhinal area (Racine et al., 1983). In this thesis 
hippocampus will be the target for measurement of lipid or PCB influenced LTP and 
excitability. 


Released extracellular glutamate in the synapse usually undergo high affinity uptake 
into astrocytes (Schousboe et al., 1977). In the astrocytes glutamate will react with 
ammonium by the help of glutamine synthase and adenosine triphosphate (ATP) to 
form glutamine. This reaction is highly important in detoxifying ammonium, since 
high concentrations will disturb synaptic function (Nissim, 1999;Sonnewald et al.,
1997;Norenberg et al., 1997). Glutamine is not a neurotransmitter and is released from 
the astrocyte in to extracellular spaces, where it is taken up by the presynaptic terminal 
and converted back to glutamate by glutaminase. Glutamate are also involved in 
metabolic pathways like the citric acid cycle (TCA-cycle) and will here be transformed 
into other amino acids like f.eks GABA (Roberts & Rankel, 1950;Waagepetersen et 
al., 2005). Glutamate from the cytosol will accumulate in vesicles due to vesicular 
glutamate transporters (VGlut), which are proton interchanging glutamate ports (Tabb 
et al. 1992). This is due to proton-dependent ATPases in the vesicle membrane that 
creates a proton-based electrical gradient. For the accumulation of glutamate to happen 
it is important with positively charged vesicular lumen (full of H+) in addition to low 
pH (Tabb et al. 1992).  
15


Glutamate receptors have L-glutamate as a primary activator and are a diverse group, 
including ionotropic (NMDA-, kainat- and AMPA-receptors) and G-protein-coupled 
metabotropic receptors (mGluR). The ionotropic glutamate receptors mediate fast 
excitatory synaptic transmission that are normally not voltage dependent (except 
NMDA receptors), while the g-coupled mGluR are involved in secondary messenger 
pathways mediating slow modulatory responses. N-methyl-D-aspartate (NMDA) in 
addition to AMPA receptors are suggested as important for memory processes and are 
found in particular high densities in the hippocampus and cerebral cortex(Roberts & 
Rankel, 1950;Wheal et al., 1998). The NMDA receptors are voltage dependent 
(requires initial depolarization), ligand gated (requires binding of co-agonists), non-
selective cation channels that are composed of two subunits of multiple combinations. 
Functional NMDA-receptors are normally composed of one NR1 and at least one 
NR2-subunit (Kew & Kemp, 2005), although these exists as several variants. NR1 can 
exist in seven splice variants while NR2 can be encoded by four different genes giving 
a total of 11 different subunits that can be combined. Due to high subunit diversity and 
their combinations, there can be many variants of this receptor. It's also worth to notice 
that there are several ways of modulating NMDA receptors as there are 6 known 
binding sites for different substances that can influence the receptor activity. 
Activation of the NMDA receptor requires not only binding of the main agonists but 
also binding of a co-agonist (glycine or d-serine). In addition, the ion channel is during 
normal resting potential blocked by Mg2+ and initial depolarization is necessary for the 
Mg2+ to disassociate allowing influx of Na2+, small amounts of Ca2+ and outflow of 
K+. Immediately after the Mg2+ is disassociated it re-binds due to strong attraction to 
its site in the ion channel, leading to inhibition of further ion flux through the channel. 
The influx of Ca2+ is thought to be the main mechanism behind synaptic plasticity 
formation, since Ca2+ might lead to several intracellular cascades of events.  NMDA-
receptors are also due to their complexity, slower and requires several factors to be 
present than the other ionotropic glutamate receptors (AMPA or Kainate) (Meldrum, 
2000). AMPA receptors have lower affinity for glutamate than NMDA-R although, 
when activated, they have much faster kinetics (Meldrum, 2000). Normally, NMDA, 
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AMPA and Kainate receptors are enriched in postsynaptic densities (PSD) and 
coupled to PSD associated proteins. This enrichment of NMDA-receptors as well as 
AMPA-receptors in certain areas leads to increased chances of ion-channel opening 
when successful stimulation does occurs. Activation of one receptor gives a local 
depolarization, which removes the Mg2+ blockage, leading to increased chances of 
activation of the neighbour NMDA receptors in the local area. 

LTP can be created by agonists activating the NMDA receptor with continuous 
patterns of stimulation, which leads to increased plasticity in the synapse, making it 
more sensitive to stimulation and increase chances of new stimulation (Bliss & 
Collingridge, 1993). The relationship between AMPA and NMDA receptor has also 
been suggested to be important(Williams et al., 2007). In addition it is suggested that 
dopamine stimulation of D1 subunit could change NMDA-receptor sensitivity. This is 
thought to be a synergistic regulation since it leads to decreased dephosphorylating of 
the NR1-subunit of the NMDA-receptor (Snyder et al., 1998). 
ͳǤͷ

Although high, the concordance of monozygotic twins mentioned earlier is not perfect, 
suggesting that environmental factors may act in additive or interactive ways with the 
genetic influence (Caspi & Moffitt, 2006;Willcutt et al., 2007). Identifying possible 
causes and increasing our understanding of the mechanisms behind ADHD is 
important in treatment and prevention of symptom development. Although individuals 
with ADHD do not always express the same polymorphisms, there are some that are 
frequently represented. Some of these polymorphisms have been found in genes 
coding for serotonin- and dopamine- transporters and receptors, glutamate receptors 
and solute carrier protein (9A9) (Akutagava-Martins et al., 2013).  Several studies of 
blood parameters and early clinical studies have implicated that ADHD patients may 
have a dysregulation in the fatty acid metabolism, but also that lactational exposure of 
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PCBs could induce changes in gene expression of fatty acid-metabolism proteins and 
proteins involved in dopaminergic signalling (Sazonova et al., 2011). 

While PCB was widely used in industrial products since the 1920s, suspicion of 
adverse effects in wild animals and in humans was first raised in the 1970s. Although 
they are forbidden, their persistence in the environment and in organisms combined 
with their lipophilic properties has led to bioaccumulation. Although the levels are 
declining in nature, they are still high in some organisms on top of the food chain. It is 
also worth noticing that different PCB-congeners and mixtures can give a diverse 
spectrum of toxicity. Industrial mixtures of different PCBs types have shown to 
influence a variety of gene expressions also involved in the dopaminergic transmission 
system (Sazonova et al., 2011).The effect of PCBs is highly dependent on the type of 
PCB, dosage and development stage of the exposed individual (Sazonova et al., 2011). 
PCB-congeners have 209 different possible structures and are hence named PCB 1 to 
209. The different PCBs are distinguished by the amount of chlorination and whether 
they are in para-, meta- or ortho- positions on the biphenyl structure (figure 1.). The 
chlorination determine the mechanism of action and the persistence and toxicity in 
biological systems (Safe, 1984). PCBs can be divided in to two main groups, namely 
coplanar (non-ortho substituted) and non-coplanar (ortho-substituted) PCBs. The 
coplanar PCBs have no chlorine atoms in ortho-position leading to a planar 
relationship between the two phenyl rings. The non-coplanar PCBs have chlorine 
atoms in at least one ortho-position, forcing the two phenyl rings into different plane.  
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Figure 1: Structure of the PCB biphenyl skeleton. Chlorine atoms are bound to the 
biphenyl structure in meta-, ortho- or para-position (2-6). There are 209 theoretically 
possible congeners (including isoforms). The persistence and toxicity  is determined 
by the number of chlorine atoms and their positions (ortho-, meta- or para-) also 
determine their toxicity (Safe 1984).
Non-ortho PCBs are very similar to the structure of dioxins, and might therefore 
induce similar effects as dioxins. The dioxin-like PCBs are able to induce increased 
liver enzyme production by binding to the aryl hydrocarbon-receptor (AhR). AhR 
inducing PCB-molecules includes mostly non-ortho PCBs with 4-6 chlorine atoms in 
meta- and para- positions. The AhR is coupled to heat shock protein 90 (HSP90) and 
are present in the intracellular fluid. When PCB binds to the AhR, Hsp90 is released 
and the PCB-AhR-complex is transported inn to the nucleus. The release of Hsp90 
uncovers the DNA binding site for aryl hydrocarbon receptor nuclear translocator, 
which is a transcription factor that can bind to DNA. Most of the activated genes are 
coding for enzymes involved in biotransformation, and could lead to increased 
turnover (detoxification) or bio activation (increased toxicity) of xenobiotics (Hansson 
et al., 2006). Also genes coding for enzymes responsible for thyroid hormone 
conjugation and metabolism of retinol seems to be influenced (Durham & Brouwer, 
1989). Exposure to large amounts of non-ortho PCB-molecules might in addition 
result in chlor-acne and hyperpigmentation (Luecke et al., 2010). They have also been 
suspected to be involved in carcinogenesis, disturbed hormone balance and impaired 
immune function (Yoshizawa et al., 2007;Davis & Safe, 1990). PCB exposure might 
also lead to changes in tissues and liver dysfunction caused by necrosis and fibrosis, 
probably due to changed contents of lipids, cholesterol, porphyrin and retinol.  
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In body tissue from mammals, birds and fish it has been found that the ortho-
substituted PCBs are dominating (Mariussen & Fonnum, 2001). Studies have shown 
that these types of PCBs could lead to changes in behaviour, which involves both hypo 
and hyperactivity (Eriksson et al., 1991;Holene et al., 1998;Johansen et al.,
2011;Johansen et al., 2014). Certain types of ortho-PCBs have also shown to be 
especially good activators of the Ca2+ transporting ryanodine receptor (RyR) (Pessah et 
al., 2006). Alterations in Ca2+ homeostasis and subsequent intracellular second 
messengers have been proposed to be involved  in developmental neurotoxicity (Unni 
et al., 2004;Tilson & Kodavanti, 1998). 
Other changes in brain parameters includes both short and long term changes to the 
muscarinic cholinergic receptor and  dopamine uptake inhibition in vesicles  (Eriksson 
et al., 1991;Mariussen & Fonnum, 2001). Considering the large role of dopamine in 
ADHD, it is also notable that a recent study have confirmed that especially ortho-
substituted PCBs might bind to DAT (Wigestrand et al., 2013) with PCB 110 possible 
being as potent as cocaine. The thyroid and retinol homeostasis was found as one of 
the ortho-substituted PCB 180s most sensitive physiological parameters discovered in 
WKY rats (Viluksela et al., 2014). Changes in thyroidal hormones might as well lead 
to severe effects on the thyroid gland, which is highly important in normal 
development of the brain. Early disturbances in the thyroidal gland can therefore 
possibly influence hearing, motoric and intellect (Porterfield, 2000).  
Also studies on humans have found correlation between psychomotoric impairments 
and the degree of PCB burden (Gladen et al., 1988). Although, it is important to notice 
that human studies often includes several confounding factors as they are naturally 
exposed to a multitude of substances. The prenatal and lactational part of life is 
considered to be the most vulnerable regarding developing neurological damage due to 
PCB-exposure (Chevrier et al., 2008;Sazonova et al., 2011;Schantz et al., 2003). This 
is therefore interesting in regard to ADHD which is believed to be a 
neurodevelopmental disorder.  
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
Dietary fat is one of our most important macronutrient, not only containing lipids but 
also vitamins. Fatty acids are thought to be important in cellular development and 
maintenance, and might influence cell membrane fluidity, neuronal function and 
signalling (Su, 2010;Kim et al., 2011;Cao et al., 2009;Muskiet, 2010). The human 
diets have been changing gradually since the agricultural revolution approximately 10 
000 years ago, with accelerated changes being introduced during the industrial 
revolution approximately 200 years ago (Cordain et al., 2005). From the nutritional 
and anthropological point of view, humans have developed on a diet with a fair 
amount of n-3 FAs, whereas many industrial diets of today contain less n-3 FAs and 
more n-6 FAs and SFAs (Muskiet, 2010). Both n-3 and n-6 fatty acids are essential 
and must be provided primarily through diet (Richardson, 2006). Polyunsaturated n-3 
FAs like DHA and EPA are abundant in brain tissue and are necessary for proper 
neurological functions including G-protein signalling (Janssen & Kiliaan, 2014;Litman 
et al., 2001).  
Many studies implicate that cognitive dysfunction in ADHD may be escorted by a lack 
of n-3 PUFAs, during embryonic development and early life (Antalis et al.,
2006;Dopheide & Pliszka, 2009;Peet & Stokes, 2005). This association is believed to 
root in nutrition sensitive polymorphisms in patients predisposed to ADHD. A recent 
study shows that children with low scores on cognitional tasks receives improvement 
on these tasks after DHA supplement, while children with higher scores did not 
improve (Richardson et al., 2012). This suggests that low scores might be associated 
with DHA deficiency, but also that the response is highly dependent on genetics. The 
findings have been varying in older studies and could possibly be due to the absence of  
genetic considerations. Despite variation, other studies have also found some 
association with DHA supplementation and improved cognitive performance (Willatts 
et al., 1998;Bloch & Qawasmi, 2011a;Henriksen et al., 2008;Helland et al.,
2008;Birch et al., 2000). The clinical research evidence on n-3 FAs as an ameliorating 
compound on cognitive disturbances are limited, and further research have been 
warranted (Peet & Stokes, 2005). We therefore chose to study possible effects of long-
term n-3 PUFA supplementation on SHR and WKY rats. 
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ʹǤ
The working hypothesis explores the effect of environmental factors such as dietary 
fatty acids and PCB153 on the neostriatal dopaminergic synapses in different genders 
and genotype. In addition, we wanted to investigate if the SHR animal model of 
ADHD have an increased sensitivity to any of these compounds. We want to explore 
this by studying the dopamine, serotonin and glutamate signalling-dynamics in 
specific brain structures (striatum and hippocampus, respectively) after introducing a 
toxin (PCB 153) that is suggested to make the symptoms worse and polyunsaturated 
fatty acids that is suggested to ameliorate the ADHD symptoms. By introducing a 
toxin and a suspected ameliorating compound, we aim to identify eventual 
neurochemical responses in brain areas associated with learning and motivation. The 
aim of this study was to investigate how these two compounds effected behaviour and 
related biochemical parameters. We have therefore investigated if: 
Polyunsaturated fatty acids: 
1) Change ADHD symptoms in the SHR-rat. 
2) Have effects on the dopaminergic synapse, by studying the nigrostriatal 
pathway and if a general increase in n-6 FAs could give the same effect as 
n-3 FAs. 
3)  Have same effects on both genders and on the SHR-ADHD model 
compared to WKY- control rat strain. 
PCB 153: 
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4) Have effects on the dopaminergic synapse, by studying the nigrostriatal 
pathway, performing analyses in neostriatal tissue and electrophysiological 
activity measurements of the hippocampus detecting possible changes in 
dopaminergic modulation of the mesocortical pathway. 
5) Have genotype specific effects in the SHR-ADHD animal model and the 
control WKY-rat. Since our hypothesis suggests that ADHD-genetics and 
thus SHR-genetics might represent increased vulnerability to environmental 
factors. 
6) Have gender specific effects, especially since ADHD is regarded as a 
gender dependent disorder. 
͵Ǥ
͵Ǥͳ
The spontaneously hypertensive rat (SHR) is considered one of the best available 
animal models of ADHD (ADHD-C). It is a genetic model of ADHD and hypertension 
that have derived natural from the Wistar Kyoto /NHsd (WKY) rat strain by prolonged 
isolation. In operant behavioural tests the SHRs show hyperactivity, impulsivity and 
reduced attention compared to WKY-rats(Sagvolden et al., 2009), and also if 
compared to Sprague Dawley rats. Although many rat strains might show similar 
behaviour as the WKY, they may not have the same genetic and levels of biological 
markers. This also comprise outbred WKY strains like Wistar Kyoto from Charles 
River (WKY/NCrl) which exhibit divergence in behavioural tests, showing inattention 
compared to WKY/NHsd. The WKY/NCrl is therefore proposed as an animal model 
of ADHD-PI and cannot be used as a control for SHR-rats (Sagvolden et al., 2009). It 
is therefore important to select a proper control-strain to avoid misinterpretation of 
acquired data and spurious results. Since the SHR-rat strain has developed from the 
23
WKY/NHsd, they should be more genetically similar than any other rat strain making 
them the most proper control for studying the SHR-rats. Exposure of WKY-rats to di-
ortho-substituted PCB-congeners during development have in some tests shown to 
result in changed behaviour which is similar to SHR behaviour (Holene et al., 1998). 
The SHR-rat model has been extensively studied in details and shows exceptional 
validity in behavioural symptoms in a variety of behavioural tests. In general, SHR-
rats respond well to d-amphetamine, methylphenidate and guanfacine resulting in 
reduced hyperactivity (Sagvolden et al., 2005b;Sagvolden, 2006). Since there is no 
known specific genetic and neurological benchmark marker to define ADHD, the 
validity of the biological mechanisms can therefore not be emphasized too much. 
Although there are polymorphisms in related gene families that seem to be present 
more often in ADHD subjects, one cannot state that all subjects with the given 
polymorphism will exhibit ADHD-like symptoms (Akutagava-Martins et al., 2013).  
Since SHR-rats are the currently best validated model of ADHD, we chose to perform 
our experiments on both the SHR-rat and on its appropriate control; the Wistar Kyoto 
rat (Sagvolden et al., 2009). 
͵Ǥʹ

In our animal facility, the standard rat feed consists of 5% (w/w) FAs (LFA) giving 
11% of total calorie intake. A calorie intake of 11% from fat might be considered as 
fairly low compared to western diets with an average at  35% (Lee et al., 2001). 
Although several studies have suggested that the type of fat is more important than the 
amount; the American Academy of Pediatrics recommends to maintain the calorie 
consumption of fat to 20-30% (Lee et al., 2001). The FAs found in human diets 
depend on many factors, including geography, socioeconomic status and culture. In the 
coastal areas or Inuit people there is usually a high intake of n-3 PUFAs compared to 
inland populations or populations with low marine seafood culture. Therefore it was 
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important to also investigate the effect of low fat diet (with 11 % of total kcal from 
~5% FAs) to a more normal high fat diet (LFA; 40 % of total kcal from ~20% FAs), as 
well as investigating if there were differences between an western diet (SFA; rich in 
SFA and n-6 FAs) compared to a Inuit-diet (PUFA; rich in n-3 PUFAs) (Muskiet, 
2010).  
The 20% SFA-rich diet induced a significant increase in the weight of both WKY and 
SHR rats, compared to the 5% FA-diet. In contrast the 20% PUFA-rich diet induced a 
small (paper I) or no weight gain (paper II). It is also worth to notice that we changed 
distributor of the PUFA-diets between paper I and paper II, which also led to a  slight 
change in the n-3 FA composition. In paper I, the n-3 content were present as almost 
equal amounts of DHA (40%) and EPA (60%), while this ratio was changed to mainly 
DHA (80%) and EPA (20%) in paper II.  Since there are different amounts of fat and 
different fatty acids present in the diets, the rats could have preferences, making them 
ingest different amounts of feed. Therefore we also performed fatty acid analysis with 
Gas chromatography (GC) of the cortical brain tissue, to see if the diets could reach 
the brain and induce a change in the lipid composition. While there was few changes 
in the SFA-fed groups with no effect on the n-3 FA proportion, the PUFA-diet induced 
significant increases in the cortical n-3 FA proportion, giving a higher n-3/n-6 ratio in 
the cortical tissue.  

In humans and mammals non-coplanar PCBs have been especially associated with 
problems in cognition. These PCBs are found in high concentration in both nature and 
human milk. PCB 153 is the most dominant congener in human milk and has a slow 
turnover in human tissue of 25 to 30 years (Cerna et al., 2010;Seegal et al., 2011).For 
this reasons we have chosen to study the di-ortho-substituted PCB congener 153 in this 
thesis.The total dose of PCB 153 used (9 and 18 mg PCB/Kg bodyweight) is similar 
to a tissue concentration range found in wild animals (Skaare et al., 2000). The dose 
was divided in sub-doses of 3 and 6 mg/Kg that were administered orally three times 
during lactation, to avoid acute toxicity. Because we have recently observed 
behavioural changes attributed to PCB 153 (Johansen et al., 2011;Johansen et al., 
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2014), this study focused on whether PCB 153 interfered with aspects of glutamatergic 
excitatory and dopaminergic/serotonergic modulatory neurotransmission.

͵Ǥ͵
The function of the dopaminergic striatal synapses is linked to various types of 
learning including reward based learning, habits and procedural skills . The dopamine 
content of the nigrostriatal synapses is high, compared to other brain areas like cortex 
and hippocampus. The dopaminergic terminals communicate with cholinergic 
interneurons and GABAergic efferent neurons mainly through D5 and D1-receptors 
respectively. Hippocampus is another brain structure known for its importance of 
information processing leading to learning and memory formation, which seems to be 
linked to encoding of prediction error of reward, cue outcome-associations of novel 
responses and mismatch signals (Delgado & Dickerson, 2012). The hippocampal 
neurons are primary of glutamatergic nature, although they are modulated by 
dopamine and GABA (Lang et al., 2014;Shohamy & Adcock, 2010). Although not 
much is known about the function of the anatomical connection between hippocampus 
and striatal tissue (cortico-striatal circuit), some studies implicates that it is important 
for reward-based learning (Delgado & Dickerson, 2012;Pezzulo et al., 2014). The 
dynamic developmental behavioural theory of the neurologic mechanisms of ADHD is 
based on the hypothesis that altered dopaminergic function leads to impaired 
modulation of non-dopaminergic (primarily glutamate and GABA) signal 
transmission. In addition it is suggested a hypofunctioning mesolimbic dopamine 
branch in ADHD (Sagvolden et al., 2005a). Dysregulation of the dopaminergic system 
seems to be highly relevant with regard to ADHD. In addition, both striatum and 
hippocampus seems to be possible areas important for the neuropsychological 
symptoms of this disorder. Therefore, we chose to study biological parameters 
primarily in striatum and additionally in the hippocampus.  
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ͶǤ

The dopamine turnover of untreated prepubertal (p30) SHR rats (paper III), had a 50% 
lower turnover than age-matched WKYs, while at adult age (p60) this difference was 
almost vanished between these two strains. This is due to an age dependent decrease in 
dopamine-turnover, which was predominant in WKY. A similar age dependent 
reduction was also found in the serotonin-turnover, although no significant differences 
was found between WKY and SHR. In general the basal level of dopamine, serotonin 
and dopamine-related proteins like DAT, VMAT-2 and TH as well as D1R and D5R 
were the same in both the WKY and SHR rat strains. In paper I, we also observed a 
higher neostriatal levels of GABA in adult WKY, compared to the SHRs. Since 
ADHD is also believed to be highly linked to dysfunction in the dopaminergic system, 
the low dopamine-turnover in the young SHRs might be of high relevance to the 
symptoms of the SHR rats.  
	
Paper I. This study investigated if n-3 PUFA-supplement during development could 
ameliorate ADHD symptoms in the SHR-rat model of ADHD. Here we gave the SHRs 
one experimental n-3 PUFA-enriched diet with 20% total fat, while the control SHRs 
received the standard animal facility diet containing mainly n-6 FAs with 5% total fat. 
In the behavioural studies, n-3 rich feed led to improved reinforcer induced attention in 
males, while inducing a reduction in spontaneous locomotion in both genders. Further, 
a n-3 PUFA effect restricted to males involved a 30% decrease in dopamine-levels and 
an increased turnover. The turnover was practically doubled in the SHRs that received 
the n-3 FA supplement. In addition, a similar n-3 FA induced change was observed in 
the serotonergic system with a 40% reduction of serotonin and a four times increased 
serotonin turnover, both restricted to male.
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Paper II. Further investigation was performed on males of both WKY and SHRs at 
p30 instead of p60. The feeding procedure was the same as in paper I, by giving diets 
before and during pregnancy and development. The experimental diets included two 
high FA-diets with 20% fat, one containing mainly n-6 FAs as and the other 
containing mainly n-3 PUFAs. They were compared to a control group fed the 
standard animal facility diet for rats which contained low levels of FAs (5% fat). FA-
analysis of cortical tissues was performed and showed that the n-3 FA diet lead to 
increased n-3 FA in the tissue, while n-6 FA diet did not. Further, we found that both 
FA-enriched diets could lead to the same dopaminergic modulation in both WKYs and 
SHRs, as seen in paper I. The n-3 FA was the most potent and led to larger effects on 
the protein levels including DAT, as well as on the turnover in both SHR and WKY 
rats. Although the SHRs responded to the FAs in a similar way as WKY, the responses 
were weaker and did not reach significant levels for all parameters. 
ͳͷ͵
Paper III. In this paper we investigated the effect of postnatal exposure of PCB 153 
on the dopaminergic striatal system and the LTP obtained  in the hippocampus of 
standard WKY rats.  We found that PCB 153 exposure led to a 250 % and 115% 
increased level of the metabolite of dopamine and serotonin; HVA and 5-HIAA, 
respectively, without influencing the overall levels of dopamine and serotonin. This 
led to a 4 and 2 times increase in the calculated turnover rates of  dopamine and 
serotonin, respectively.  There were no effects on the general amino acids. At the same 
time we did find a pathway specific increase in LTP magnitude of the stratum oriens 
(no effect in stratum radiatum) in hippocampus without effecting the basal synaptic 
transmission in the same strata.     
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Paper IV. Further we wanted to investigate if the PCB 153-effect was the same in the 
SHR as in WKY, and if there were any gender specific effects. In this study we 
focused mainly on the measurements of dopamine, serotonin and their respective 
metabolites, in addition to measurements of dopamine associated proteins. Here we 
did also find an increase in the HVA and 5-HIAA –levels in all but the female SHRs, 
without effecting dopamine or serotonin levels. When looking at the dopamine 
associated proteins we found a reduction of DAT in the WKY males only as well as a 
reduction in D5R in all group without any effects on D1R. Reductions of PSD-95 
proteins were restricted to the males of both genotypes. At the same time no effects 
were seen on TH or VMAT-2. It might be proposed that increased HVA results from 
inhibited reuptake of  dopamine through DAT. Most likely, the measured down-
regulation of D5R might either be due to compensatory mechanisms of 
dopaminoceptive cells or degradation of postsynaptical targets (as seen by a decrease 
of PSD-95 in males), possibly due to increased dopamine-induced stress. In the overall 
results we found that there were fewer significant effects in the female rats of both 
strains. Also, the SHRs of both genders seemed to respond less than the gender 
matched WKYs. In this set of data we reused the monoamine results of WKY male 
from paper III, to compare to the females and the SHRs, but there was also added new 
additional measurements to the male WKY groups for this paper.
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

Mapping of dopamine dynamics during postnatal development in the animals showed 
that there was a hypoactive dopamine-turnover in SHR compared to the WKY which 
was larger at p30 compared to p60. This difference is supported by a previous study 
showing 25% less effective COMT in the SHRs (Masuda et al., 2006), in addition to 
another work, showing enhanced DAT reuptake in the SHRs (Miller et al., 2012). 
Both of the findings may contribute to restrained HVA formation and lead to lower 
turnover rates. In the our first study (Paper I) where we examined (p60) SHR-rats of 
both genders after receiving diets with either 5% FAs or 20% PUFAs we found gender 
dependent effects restricted to males. These data made us perform further analyses in 
paper II on males at 30 only, where we also included both WKYs and SHRs exposed 
to the experimental diets with the proportion of dietary at 5% (LFA) and 20% w/w 
(SFA or PUFA respectively). 
In the initial study (Paper I) we measured ADHD related symptoms in adult (p60) 
SHR-rats of both genders receiving diets with either 5% FAs or 20% PUFAs. It was 
clear that there was a gender-dependent response to the PUFA-diet, where several 
responses were restricted to males, such as ameliorated impulsiveness, inattention and 
increased dopamine-turnover, while both genders got a reduction in general 
movement. The reason for this remains unknown, although it could be due to sex-
hormone sensitivity of FA-acid metabolism (Kelly et al., 2014;Petrovic et al., 2014). 
The behavioural and dopaminergic data of SHRs from paper I, implied that the PUFA-
supplement improved behaviour compared to the LFA-diet, with greater effects in 
males. Because of low levels of FAs in the control diet, it was difficult to conclude 
whether this behavioural effect was a result of the n-3 PUFAs or a result of increased 
level of general FAs. Although the uncertainty, a published paper showed that high-fat 
diet should led to reduced mesolimbic dopamine-turnover and unchanged dopamine-
levels (Davis et al., 2008). Since these results were opposite from what we found, we 
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made a preliminary conclusion that the effect we found in paper I, could be due to the 
n-3 PUFA supplement. 
 In paper II, we found that increasing the dietary fat content from 5% to  20%, 
regardless of whether it contained SFA or PUFA, had large impact on the neostriatal 
DA system in both male  WKY and SHR. Although SFA led to similar effects, n-3 
PUFA had an even larger effect than SFAs on the dopamine-turnover and the related 
synaptic proteins. It should be emphasized that it is a weakness of the study design that 
we were unable to measure the behavioural parameters of the animals used in paper II, 
therefore giving no behavioural results for WKY rats receiving n-3 PUFAs or SFAs as 
well as for the SHRs receiving SFA. Since the neostriatal dopamine system of both 
WKY and SHR reacted in a similar way with the SFA-diet as with the PUFA-diet, it is 
highly likely that the fat content of the standard animal facility diet (LFA) is 
insufficient, particularly considering that normal human diets should preferably 
contain 20-30% w/w fat (Lee et al., 2001). Since the SHRs received behavioural 
benefits from increased fat  as well as reaching a dopamine turnover similar to WKY, 
this implies that the SHRs might need higher amounts of dietary fat than the WKY to 
achieve proper dopamine signalling (Miller et al., 2012;Masuda et al., 2006). The 
WKY-rats received a greater boost of their dopamine turnover than the SHR after 
PUFA-supplementation. Before drawing any conclusion of the benefit of SFA and 
PUFAs in the WKY animals, it would be necessary to measure their behavioural 
parameters. 
Furthermore, the SFA and PUFA-dependent decrease in the levels of both TH and 
VMAT-2, could explain the decreased dopamine level. Strangely, the cells managed to 
keep the dopamine signalling and turnover rates stable, while increasing it with the 
PUFA-diet. Another study also demonstrate that dietary restriction of  FAs could lead 
to an increased amount of TH as well as a VMAT-2 level, most likely leading to 
higher dopamine levels like we found in the LFA-diet (Bondi et al., 2014). The study 
also confirmed our results by demonstrating lower VMAT-2 and TH levels due to n-6 
or n-3- FA supplemented diets (Bondi et al., 2014;Narendran et al., 2012). The 
concordance of the TH and VMAT-2 regulation found in paper II and by Bondi et al. 
31
might be due to a TH and VMAT-2 complex on the synaptic vesicles (Cartier et al.,
2010;Bondi et al., 2014) therefore a reduction might possibly implicate a decrease in 
amounts of vesicles. Although reduced VMAT-2 might mean that the vesicle uptake is 
reduced, the amount of DA may also be reduced. The PUFA induced increase in 
dopamine turnover might possibly be due to the increased down regulation of DAT, 
which was larger than in the SFA group. The PUFA induced reduction of DAT have 
most likely resulted in reduced dopamine reuptake by the presynaptic neuron, leading 
to increased amounts of extracellular dopamine, giving a Ritalin/amphetamine-like 
effect. Our discovery of SFA and PUFA-enhanced dopamine turnover was 
unexpected, as another study has shown opposite effect on dopamine-turnover after 
high FA-diets (Davis et al., 2008). However, our use of HVA as marker for 
extracellular dopamine degradation may give a more detailed picture of dopamine 
available for stimulation of receptors than DOPAC (Jones et al., 1998). 
We did not see any changes in the D1/D5-type receptors, suggesting no compensatory 
effect of these receptors on cholinergic and GABAergic interneurons or the efferent 
GABAergic neurons (Berlanga et al., 2005) Finally, a significant reduction in PSD-95 
was induced only by PUFAs and might implicate changes in postsynaptic 
glutamatergic neurons and their glutamate receptors (El-Husseini et al., 2000;Rao et 
al., 1998;Sans et al., 2000). Except for the changes in dopamine levels and turnover, 
the SHRs failed to reach significant levels of confidence on the TH, DAT and VMAT-
2 levels. The lower sensitivity to SFA and PUFA might be a reflection of possible 
underlying dysfunctions in SHRs dopamine metabolism and regulation (Miller et al.,
2012). 
Since the SFAs also were able to induce changes in the dopamine system which were 
similar although slightly less effective, than PUFAs, it could be possible that the SFAs 
are metabolized less effectively, to some of the same active compounds as PUFAS. 
However, when we measured total FAs from cortex, we did not find any increase in 
the n-3 FAs in those only receiving SFA-diet. In contrast, we did find significant 
increases in n-3 PUFA levels in the group that received PUFA-diet, showing that the 
feeding was successful and that the lipids were distributed to the brain. For future 
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studies, it would be interesting to measure different behavioural parameters also for 
animals which have been treated with the SFA-type diet to find out if n-6 also may 
induce similar behavioural changes as n-3 PUFA did. Studies on children have also 
shown that n-3 PUFA supplements might be beneficial for reading and behaviour, 
especially for underperforming children with lower reading and behavioural scores 
(Bloch & Qawasmi, 2011b;Richardson et al., 2012). In one of the recent studies the 
placebo group receiving n-6 FAs did not achieve the same benefits as the group 
receiving n-3 PUFAs (Richardson et al., 2012). It would also be interesting to 
investigate what the reduction of PSD-95 might mean to the incorporation, amount and 
function of glutamate receptors in the neostriatum.  
ȋȌ
The level of HVA and 5-HIAA are good markers of released dopamine and serotonin, 
respectively. The PCB-induced increase in HVA-levels in both WKYs and SHRs of 
both genders, described in paper III and IV, is most likely due to the reduction in 
DAT-levels. DAT impairment leads to accumulation of extracellular dopamine by 
inhibiting reuptake and making dopamine a candidate to degradation to HVA. We 
found a PCB induced reduction of DAT in WKY male together with a tendency of 
reduction in SHR male and in the females of both strains. A recent study (Wigestrand 
et al., 2013) demonstrates that PCBs also have the ability to bind to DAT, leading to 
dopamine-reuptake inhibition. The unaffected dopamine levels found in both WKY 
and SHR of both genders, were also supported by the finding of unchanged TH levels. 
High dopamine production and reduced DAT can contribute to accumulation of 
dopamine in the extracellular space and explain the increase in HVA-levels that we 
observe. The dopamine degradation process by COMT is necessary for clearance of 
extra-vesicular dopamine and might be especially important during reuptake 
inhibition. Clearance of dopamine by COMT have previously shown to be impaired in 
the SHRs (Masuda et al., 2006), in addition to a recent work showing enhanced 
reuptake of dopamine by DAT in the SHRs (Miller et al., 2012), both of which might 
be an explaining factor for the low PCB-induced dopamine turnover found in the 
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SHRs compared to the WKYs of both genders. High amounts of free dopamine can 
also be bio-transformed to the toxic metabolite called 6-hydroxydopamine which is  
damaging to the dopamine producing cells (Zigmond et al., 2002). Excess extra 
vesicular dopamine have been suspected to result in increased chance of 6-
hydroxydopamine formation, and might therefore be disadvantageous (Graumann et 
al., 2002). Since the degradation of free dopamine by COMT might be impaired in the 
SHRs in addition to enhanced DAT uptake, these rats could face a greater risk of 6-
hydroxydopamine formation and toxicity (Liao et al., 2003;Masuda et al.,
2006);(Miller et al., 2012). The female SHRs had the lowest PCB-induced increase in 
HVA-levels and was the only group that failed to show significant enhanced 
dopamine-turnover. Like HVA and dopamine, 5-HIAA was also highly increased 
while serotonin remained stable in both WKYs and SHRs except for the female SHRs. 
Also here, the female SHRs failed to receive significant enhancement of serotonin 
turnover, unlike the other groups, as well as it only was a small but insignificant 
increase in 5-HIAA. This shows that PCB 153 most likely works in the same ways on 
both of  the dopamine and serotonin transmitter systems. Another finding was that the 
D5 receptor were significantly down-regulated by PCB 153, whereas D1-receptors 
was unchanged for all strains and genders. A down-regulation of D5 receptors could 
be regarded as a compensating mechanism by the cholinergic interneurons in response 
to excess dopamine, by reducing the availability of these targets. In contrast, D1 
receptors are located mainly on the efferent GABAergic neurons. The failure of D1Rs 
to respond to PCB in a similar manner as the D5R, could indicate possible inability of 
the D1Rs to compensate for increased stimulation of dopamine or alternatively that 
they are more insensitive to increased dopamine levels (Sunahara et al., 1991). Further 
research should be performed to investigate if the cAMP-levels in these neurons are 
changed, as this would be a good indicator of the postsynaptic response to the excess 
extracellular dopamine levels (Walaas et al 2011).  
PSD-95 is highly involved in scaffolding and modulation of postsynaptic receptors, 
and is especially concentrated in glutamatergic excitatory neurons. The decrease of 
PSD-95 in males only, could therefore signalise PCB-induced changes on these 
innervating glutamate neurons (Han & Kim, 2008;Kennedy, 1998) and possible 
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AMPA and NMDA activation (El-Husseini et al., 2000;Rao et al., 1998;Sans et al.,
2000). In paper III we also found a PCB-induced pathway specific increased LTP in 
hippocampus. Increased LTP has also been found in Alzheimer disease and PSD-95 
mutant mice, and were associated with reduced learning abilities. The findings of 
increased LTP and reduced learning was explained by possible disturbances of 
bidirectional synaptic plasticity (Gylys et al., 2004;Migaud et al., 1998). An increase 
in PSD-95 have on the other hand been associated with a possible compensatory 
mechanism in learning-impaired old rats (Nyffeler et al., 2007). As increased PSD-95 
can protect against impairments in the bidirectional synaptic plasticity processes.  
In the female rats we also found increased HVA and 5-HIAA, together with stable 
dopamine and serotonin levels. This findings suggest excess levels of extracellular 
dopamine levels also in these female-rats. Similar to the males, the female rats also 
responded to PCB by a reduction in the D5 receptor although the PSD-95 were 
unchanged. A down-regulation of D5 receptors could also be regarded as a 
compensating mechanism by the cholinergic interneurons, by reducing availability of 
these targets in response to excess dopamine. The reason for why we do not find a 
reduction in PSD-95, in the females could possibly be due to PCBs inability to 
significantly reduce DAT in these females, as well as a stronger tendency of increased 
VMAT-2 (WKY and SHR females; p = 0.37 and p = 0.056 respectively, whereas 
males; p = 0.39 and p = 0.30 respectively). Both DAT and VMAT-2 levels are 
important for efficient clearance of dopmaine from the synapse, and high levels 
decrease the chance of  dopamine-mediated toxicity (Liao et al., 2003).  
A recent behavioural study of rats that received PCB 153 (Johansen et al. 2014) shows 
dose dependent behavioural changes which were sex and strain dependent. This 
particular study demonstrated that the SHRs are more sensitive to PCB induced 
behavioural changes than WKYs, at the same time, more behavioural changes was 
seen in the females than in males, although few changes reached significance. Since 
the behavioural data shows magnitude of effects regarding sex and strain which were 
opposite compared to what we found in the biochemical analyses, it is possible that the 
measured biochemical changes, such as HVA and 5-HIAA, which were greater in 
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WKY and in male rats, might be of compensatory importance, by showing metabolic 
effectiveness of the excessive amounts of free neurotransmitters. Effective clearance 
and compensatory mechanisms might be important if the stimuli of these 
neurotransmitters exceed to unbeneficial levels. Effective clearance might also 
possibly reduce the chance of toxic by-product formations, such as 6-
hydroxydopamine. Because of possible lower clearing efficacy of free DA from the 
synaptic gap in the SHRs (Masuda et al., 2006), it is possible that the SHRs have a 
lower ability to compensate for possible PCB-induced dopamine-toxicity. Also the 
decrease of PSD-95 as well as D5-receptors which were greater in males than in 
females, might contribute to lowering postsynaptic targets. From these combined 
findings it is clear that PCB-153 might influence neurological processes related to 
cognition at several levels. However, the currently available biochemical and 
behavioural data of these animals makes it difficult to determine  the exact impact on 
cognitive processes. 

Taken together, this study shows that both dietary FA and PCB 153 environmental 
factors may modulate the dopaminergic system and its related proteins. It is also clear 
that there are some gender specific effects of fatty acids, with males being more 
receptive than females, but also that genetics influence the effect of these compounds 
on the dopaminergic system, where we saw a larger effect in WKYs compared to 
SHRs, which might be due to SHRs suggested hypo-functional dopaminergic system. 
Since our behavioural data,  as well as studies done by others, have showed reduction 
in ADHD-associated behaviour or cognitive improvements after PUFA-supplemented 
diets, it is likely to believe that this supplementation was beneficial. Since an increase 
in general SFA induced similar biochemical changes as PUFAS, although PUFAS was 
more potent, it looks like both of the 20% FA-diets boosts dopamine signalling 
compared to the 5% FA-diet. This enhancement might be especial beneficial for the 
SHRs, which have indications of a hypo-functional dopamine signalling. Although the 
WKY rats-got double effect of the PUFAS compared to SHRs, still remain to be done 
extended behavioural tests of these animals in order to underpin the meaning of these 
biochemical changes. The effect of PCB was distinct from that found in the PUFA 
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studies. While PCB led to increased HVA and had no effect on dopmaine levels, SFA 
and PUFA-diets lowered the dopamine levels, while HVA-levels were almost 
unchanged. Interestingly both PCB, SFA and PUFAs led to increased calculated 
dopamine turnover rates, with PCB being most potent followed by PUFAs. Excess free 
dopamine has been suggested to be unbeneficial, as it might increase probability of 
reactive dopamine species (Graumann et al., 2002). It is clear that PCB is a more 
potent agent in increasing HVA-levels, compared to n-3 PUFAs and SFA, implying 
stronger inhibition DAT reuptake of dopamine. The possible low activity of COMT in 
SHRs might also contribute to higher effect of possible dopaminergic hyperactivity 
(Masuda et al., 2006).  
ͷǤ
In conclusion, both groups of compounds led to increased transmitter turnover, 
although by distinct mechanisms. Where high FA-diets seemed to reduce the 
dopamine content, while keeping the HVA more or less stable, PCB had the opposite 
effect, by keeping the dopamine levels stable and largely increasing HVA levels. 
These environmental compounds clearly have the ability to modulate neuronal 
functions associated with cognitional processes, and may modulate behaviour. Studies 
on specific impacts of these effects on cognitive functions and overall behaviour, still 
remains limited.
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1) Ameliorate ADHD symptoms in the ADHD-animal model SHR by operant 
testing of behaviour:  
According to the initial study (Paper I) where we measured ADHD related 
symptoms in SHR-rats, the n-3 PUFA rich diet reduced ADHD symptoms in a 
gender dependent manner. Male rats obtained reduced reinforcer-controlled 
activity, impulsiveness and inattention, with no or opposite effects in the female 
SHRs. The PUFA-supplement also  led to reduced general hyperactivity in 
SHRs of both genders. These behavioural effects in the male SHRs occurred in 
concert with biochemical changes of the dopamine synapse. In the second 
study, similar biochemical changes as found by the n-3 FA enrichment were 
found to be induced by the SFA-diet, rich on saturated and n-6 FAs. 
Unfortunately we were unable to obtain behavioural data from the SFA-group. 
Therefore we cannot conclude if the ameliorating effect was restricted to a 
certain type of fatty acid. 
2) Have effects on the dopaminergic synapse, by studying the nigrostriatal 
pathway and if a general increase in n-6 FAs could give the same effect as n-3 
FAs: 
In paper II we introduced three different diets (LFA, SFA and PUFA). From 
this study we learned that a general increase in the percentage of dietary fat 
from 5% to 20% could dramatically reduce the overall dopamine level in 
neostriatum, by lowering the dopamine synthetizing protein TH. Since the 
dopamine levels were lowered and the HVA levels were stable after SFA- diet, 
the turnover (HVA/dopamine) were increased compared to the LFA-diet, at the 
same time the n-3 PUFA-diet was the only one reducing DAT-levels which led 
to slightly increased HVA levels, increasing the dopamine turnover even more 
than with the SFA-diet. The reduction of DAT could be thought of as a Ritalin-
like effect, by increasing dopamine availability in the synaptic gap. 
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3) Have same effects on both genders and have same effects on the ADHD model 
compared to a control rat strain:  
We did find gender and strain specific responses to the PUFA-diet. Firstly, in 
paper I, we showed that the PUFA-diet did not decrease dopamine levels in the 
female rats as it did in the male rats, in addition the HVA levels remained 
unchanged, resulting in unaffected turnover ratios. This lack of responsiveness 
was further reflected by the behavioural data, showing reduced reinforcer-
controlled activity, impulsiveness and inattention in male SHR, with no or 
opposite effects in the female SHRs. Furthermore, in paper II, we observed 
clear strain differences on biochemical parameters, with WKY being more 
receptive to changes than the SHR. The dopamine associated proteins TH, DAT 
and VMAT-2, were significantly reduced in WKY; the SHRs only had an 
insignificant tendency towards the same effects. Despite this, the WKY and 
SHR responded in the same way regarding the total levels of dopamine, and 
both strains responded to increased dietary FA with increased dopamine-
turnover with n-3 PUFA being more effective than n-6 FAs . 
ͳͷ͵
4)  Have effects on the dopaminergic synapse, by studying the nigrostriatal 
pathway, performing analyses in neostriatal tissue and electrophysiological 
activity measurements of the hippocampus detecting possible changes in 
dopaminergic modulation of the mesocortical pathway: 
PCB 153 had a clear effect on the dopaminergic system which involved an 
increase in free dopamine that could be degraded to HVA. We also observed 
PCB 153 mediated effects on hippocampal excitatory synaptic plasticity in the 
stratum oriens but not in the radiatum. It is clear that PCB153 did not affect the 
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total measured TH and dopamine levels, as these seemed to be stable, although 
it had an ability to increase HVA, showing that the amount of TH is able to 
compensate for the metabolised dopamine. We also discovered a reduction in 
DAT, which could be a contributing factor to the observed increase in the HVA 
level. Furthermore we also discovered increased amounts of the metabolic 
degradation product of serotonin; 5-HIAA, which also might contribute to 
modulate synaptic signalling. It is also clear that PCB have the ability to affect 
PSD-95 and D5R, implicating changes in both postsynaptic glutamatergic 
neurons, GABAergic and cholinergic interneurons.  
5) Have genotype-specific effects in the ADHD-animal model spontaneously 
hypertensive rat (SHR) and the control WKY rat. Our hypothesis suggests that 
ADHD-genetics and thus SHR-genetics might represent increased vulnerability 
to environmental factors:  
However, no clear differences were seen in the responses between WKY and 
SHR, although SHR seems to respond with lower magnitude and higher 
variability compared to the WKYs. Another genotypic but also gender-specific 
effect was found in the female SHRs, which failed to show significant increased 
turnover of both dopamine and serotonin.  
6) Have gender-specific effects, which was of importance since ADHD is 
regarded as a gender dependent disorder: 
The males seemed to respond in a greater magnitude as well as with higher p-
values compared to the females of both the WKY and SHR genotype. 
Regarding ADHD, this finding fits well, as the symptomatic display in boys and 
girls are highly gender dependent (Arnett et al., 2014).  
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